April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....
March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....
March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....
March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....
March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....
January 5, 2025GSK Plc's Strong Returns and Updates on Voting Rights and Capital Structure ~1 min.GSK plc, a leading pharmaceutical company, continues to deliver strong returns to its shareholders....
January 29, 2025Regeneron Pharmaceuticals Inc. REGN: A Leader in Biopharmaceutical Innovation ~2 min.Regeneron Pharmaceuticals Inc. (REGN) is a biopharmaceutical company known for its pioneering work in developing innovative therapies....
January 9, 2025AbbVie Inc. NYSE:ABBV Captivates Institutional Shareholders with 73% Ownership ~2 min.AbbVie Inc., the renowned pharmaceutical company listed on NYSE under the ticker symbol ABBV, boasts an impressive 73% ownership by institutional shareholders....
January 2, 2025Regeneron Pharmaceuticals: An Impressive 89% Return Over the Last Five Years ~2 min.Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been a rewarding investment for shareholders, with a solid 89% return over the past five years, according to Yahoo Finance....
January 12, 2025Vertex Pharmaceuticals Incorporated Faces Setbacks in Clinical Trials ~1 min.Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares experienced a slide recently due to setbacks in its clinical trials....
